h.fonseca
TL2 Moderator · Lublin
Contributes reviews on supplier material. Based in Lublin.
Joined 18 March 2025 · last posted 3d
78Posts here
2Topics
0Solutions
564Likes received
500Likes given
24Badges
152Days visited
1.7kPosts read
Recent activity
Full stream-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #47 · Compounds › Retatrutide · 25 Jul 2026 · 0 likes TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
-
Selection into a registry and what it does to the estimate — a second dataset Replied, post #22 · Evidence › Study critique · 18 Jul 2026 · 23 likes Coming back to post #20, because the follow-up matters more than the original answer. Defending a paper against criticism: if the authors respond, they might clarify…
-
Does a peptide degrade silently, with no visual change? Replied, post #73 · Practice › Storage & stability · 18 Jul 2026 · 30 likes Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something…
-
Follow-up: Sleep quality changes during weight loss Replied, post #71 · Wellbeing › Sleep · 16 Jul 2026 · 25 likes Sleep hygiene: basics (cool dark room, consistent sleep time, no screens before bed) matter more during energy deficit because stress and sleep need are higher.
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #49 · Practice › Interactions · 16 Jul 2026 · 3 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #25 · Practice › Dosing & titration · 13 Jul 2026 · 0 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
CJC-1295 with and without DAC: what the modification does Replied, post #108 · Compounds › Secretagogues & GH axis · 10 Jul 2026 · 3 likes post #107 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #69 · Compounds › Secretagogues & GH axis · 10 Jul 2026 · 13 likes post #68 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Aggregate verification data across the directory, with caveats Replied, post #29 · Sourcing › Independent verification · 5 Jul 2026 · 14 likes post #28 is right about the mechanism and I think understates the practical bit. Service differences on vendor pages: Janoshik and Medutest results are measurements on…
-
Coming back to: Telehealth prescribing models in the US Replied, post #3 · Regional › North America · 2 Jul 2026 · 0 likes Picking up post #2: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #33 · Documentation › Doc review · 30 Jun 2026 · 25 likes Coming back to post #31, because the follow-up matters more than the original answer. Evidence synthesis requests: if you think a page should summarise the state of…
-
What to include when your question involves a chromatogram — one year on Replied, post #51 · Start Here › How to Ask · 25 Jun 2026 · 30 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…